These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 6054071)

  • 1. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 2. The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat.
    Somberg JC; Bounous H; Levitt B
    Eur J Pharmacol; 1979 Feb; 54(1-2):161-6. PubMed ID: 421737
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of dehydrobenzperidol, quinidine and propranolol on the effective refractory time and spontaneous impulse formation of guinea pig atria].
    Schaer H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):193. PubMed ID: 4239223
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the influence of beta-receptor blocking agents, iproveratril, quinidine and reserpine on the effect of k-strophanthin in the guinea pig heart].
    Fratz R; Greeff K; Wagner J
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 256(2):196-206. PubMed ID: 4233000
    [No Abstract]   [Full Text] [Related]  

  • 5. [Actions of anti-arrhythmic agents on physiology of myocardial cell membrane].
    Mashiba H; Kanaya S
    Nihon Rinsho; 1974 Sep; 32(9):2829-34. PubMed ID: 4613891
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antiarrhythmic, cardiovascular and toxic actions of N,N'-bis-[3-(2'-ethoxyphenoxy)-2-hydroxypropyl]-ethlenediamine (Falirytmin) as compared to propranolol, quinidine and ajmaline].
    Terhaag B; Förster W
    Pharmazie; 1976; 31(9):635-9. PubMed ID: 1019213
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-arrhythmic activity in relation to calcium binding by sarcoplasmic reticulum.
    Shinebourne E; White R
    Br Heart J; 1969 Nov; 31(6):794. PubMed ID: 5358170
    [No Abstract]   [Full Text] [Related]  

  • 8. [To the mechanism of the anti-arrhythmic effect of pharmacological agents].
    Senova ZP
    Farmakol Toksikol; 1966; 29(2):177-80. PubMed ID: 4386177
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of several new antiarrhythmic agents on atrial contractility.
    Covino BG; Shannon CM
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):185-92. PubMed ID: 5353470
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative myocardial depressant effects of lidocaine, ajmalin, propranolol and quinidine.
    Tomoda H; Chuck L; Parmley WW
    Jpn Circ J; 1972 May; 36(5):433-7. PubMed ID: 5068725
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of quinidine, propranolol and their combination on experimental atrial and ventricular arrhythmias.
    Lawson JH; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):235-43. PubMed ID: 596978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the anti-arrhythmia and local anesthetizing actions of some substances].
    Diadiura ZhA; L'vov MV
    Farmakol Toksikol; 1975; 38(2):170-3. PubMed ID: 1227882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of quinidine and propranolol in experimental cardiac arrhythmias in the dog.
    Madan BR; Pendse VK
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):287-93. PubMed ID: 849075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol.
    Castellucci A
    Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
    Bianchi C; Sanna GP; Turba C
    Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
    [No Abstract]   [Full Text] [Related]  

  • 16. [New method for producing atrial arrhythmia by aconitine (cup method) and evaluation of antifibrillatory activity of ajmaline, propranolol, procainamide and quinidine].
    Nakayama K; Kumakura S
    Nihon Yakurigaku Zasshi; 1968 May; 64(3):385-92. PubMed ID: 5749309
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the cardiac activity of a new antiarrhythmic drug--pipazetate--with quinidine, procainamide, antazoline and diphenylhydantoin.
    Giuliano H
    Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):189-99. PubMed ID: 4394965
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of ouabain on the isolated guinea-pig atria pretreated by reserpine and under the influence of propranolol administration].
    Maeda K
    Nihon Yakurigaku Zasshi; 1967 Jul; 63(4):219-27. PubMed ID: 6070465
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of purified endogenous inhibitor of the Na+/Ca2+ exchanger on ouabain-induced arrhythmias in the atria and ventricle strips of guinea pig.
    Shpak B; Gofman Y; Shpak C; Hiller R; Boyman L; Khananshvili D
    Eur J Pharmacol; 2006 Dec; 553(1-3):196-204. PubMed ID: 17078946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative inotropic effects of six clinically used antiarrhythmic agents.
    Hammermeister KE; Boerth RC; Warbasse JR
    Am Heart J; 1972 Nov; 84(5):643-52. PubMed ID: 4639738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.